+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hearing Loss Disease Treatment Market Size, Share & Trends Analysis Report by Product (Devices, Drugs), Disease Type (Conductive, Sensorineural), End-user (Hospitals, Otology Clinics), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 150 Pages
  • December 2023
  • Region: Global
  • Grand View Research
  • ID: 5712451
Description Jump to:
The global hearing loss disease treatment market size is expected to reach USD 19.36 billion by 2030, registering a CAGR of 5.25% from 2024 to 2030. The growth is attributed to the global rise in disease burden, initiatives undertaken by government and private organizations to spread awareness among people, and the growing geriatric population in the world. Furthermore, the increasing number of clinical pipeline drugs and advancements with auditory devices offer lucrative opportunities for industry growth. The world is witnessing an increasing prevalence of hearing loss cases, which is the key factor driving the industry's growth.

For instance, according to the WHO reports, in 2021, over 5% of the world’s population, or around 430 million people, require rehabilitation to manage their listening disability. Moreover, by 2050, nearly 2.5 billion people are estimated to be impacted by listening impairment across the globe. As per the report, low- and middle-income countries account for 80% of people suffering from a disability. Aging has further led to an increase in the prevalence of the disease. Globally, approximately 25% of people aged 60 years are affected by hearing loss. Therefore, the rising disease cases increase the demand for treatment and drive the space. The space has the presence of a robust clinical trial pipeline, which is expected to offer better treatment options in the coming years.

This can be anticipated due to the presence of more than 45 therapies at different phases of clinical investigation. For instance, Sound Pharmaceuticals’ Ebselen and Sensorion’s SENS-401 are under phase 3 clinical studies indicated for the treatment of Meniere’s Disease and sensorineural hearing loss, respectively. Similarly, in June 2022, Pipeline Therapeutics’ phase 2 drug, PIPE-505 is being evaluated for sensorineural hearing loss. Therefore, the launch of new treatment options in the coming years is expected to offer a lucrative opportunity for the industry. Rising technological advancements, such as AI-associated innovations, in auditory products, are boosting the industry.

The launch of products with advanced features like operating through smartphones and rechargeable & waterproof devices is enhancing customer experience. For instance, in June 2022, GN Hearing launched Custom made by Resound, a chargeable hearing aid that supports wireless streaming from Android and iOS. Key players are implementing strategic initiatives, such as new launches, collaborations, agreements, and financial investments, which are further driving the industry. For instance, in April 2022, Autigen entered into a collaboration and licensing agreement with Boehringer Ingelheim to develop advanced therapies for people suffering from sensorineural conditions. Similarly, in September 2022, Fennec Pharmaceuticals announced the FDA approval for Pedmarkto prevents hearing loss in pediatric patients going through chemotherapy.

Hearing Loss Disease Treatment Market Report Highlights

  • The devices segment dominated the industry in 2023 and accounted for the maximum share of more than 90.65% of the overall revenue. This can be attributed to technological advancements in devices, high prevalence coupled with the rising benefits of devices.
  • The drugs segment is estimated to register the fastest CAGR over the forecast period due to the launch of new therapeutic products. Drugs are available for several types of hearing problems.
  • The sensorineural hearing loss segment dominated the industry in 2023 and accounted for the maximum share of more than 57.04% of the total revenue and is estimated to be the fastest growing segment over the forecast period.
  • The otology clinics end-user segment, in 2023, accounted for the second-highest share of 45.18% of the overall revenue.
  • Asia-Pacific is expected to be the fastest-growing region from 2024 to 2030 due to the rising number of target patients and funding support to major players in the region.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
1.12 List Of Abbreviations
Chapter 2 Market Definitions
Chapter 3 Executive Summary
3.1 Market Summary
Chapter 4 Global Hearing Loss Disease Treatment Market Variables, Trends, & Scope
4.1 Hearing Loss Disease Treatment Market Lineage Outlook
4.1.1 Parent Market Outlook
4.2 Penetration and Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Market Driver Analysis
4.4.1 Rising Prevalence Of Hearing Loss
4.4.2 Strong R&D Pipeline
4.4.3 Rising Awarness Amoung People
4.5 Market Restraint Analysis
4.5.1 Poor Reimbursement Facilities In Low - And Middle-Income Countries
4.6 Porter’s Five Forces Analysis
4.7 Pipeline Analysis
Chapter 5 Hearing Loss Disease Treatment Market - Segment Analysis, By Product, 2018-2030 (USD Million)
5.1 Global Hearing Loss Disease Treatment Market: Product Movement Analysis
5.2. Devices
5.2.1. Devices Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3. Drugs
5.3.1. Drugs Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.2 Systemic Steroids
5.3.2.1 Systemic Steroids Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.3 Antiviral Medication
5.3.3.1 Antiviral Medication Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.4 Vasodilators
5.3.4.1 Vasodilators Market Estimates And Forecasts, 2018-2030 (USD Million)
5.3.5 Others
5.3.5.1 Others Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 6 Hearing Loss Disease Treatment - Segment Analysis, By Disease Type, 2018-2030 (USD Million)
6.1. Hearing Loss Disease Treatment Market Share, By Disease Type, 2018 & 2030
6.2. Conductive Hearing Loss
6.2.1. Conductive Hearing Loss Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3. Sensorineural Hearing Loss Mixed
6.3.1. Sensorineural Hearing Loss Mixed Market Estimates And Forecasts, 2018-2030 (USD Million)
6.3. Mixed (Conductive And Sensorineural)
6.3.1. Mixed (Conductive And Sensorineural) Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 7 Hearing Loss Disease Treatment Market- Segment Analysis, By End-User, 2018-2030 (USD Million)
7.1. Hospitals
7.1.1 Hospitals Market Estimates And Forecasts, 2018-2030 (USD Million)
7.2. Otology Clinics, 2018-2030
7.2.1 Otology Clinics Market Estimates And Forecasts, 2018-2030 (USD Million)
7.3. Ambulatory Clinics, 2018-2030
7.3.1 Ambulatory Clinics Market Estimates And Forecasts, 2018-2030 (USD Million)
Chapter 8 Hearing Loss Disease Treatment Market: - Segment Analysis, by Region, 2018-2030 (USD Million)
8.1 Definition & Scope
8.2 North America
8.2.1 North America, SWOT Analysis
8.2.2 U.S.
8.2.2.1 U.S. market estimates and forecast, 2018-2030 (USD Million)
8.2.2.2 Key Country Dynamics
8.2.2.3 Target Disease Prevalence
8.2.2.4 Competitive Scenario
8.2.2.5 Regulatory Framework
8.2.2.6 Reimbursment Scenario
8.2.3 Canada
8.2.3.1 Canada market estimates and forecast, 2018-2030 (USD Million)
8.2.3.2 Key Country Dynamics
8.2.3.3 Target Disease Prevalence
8.2.3.4 Competitive Scenario
8.2.3.5 Regulatory Framework
8.2.3.6 Reimbursment Scenario
8.3 Europe
8.3.1 Europe, SWOT Analysis
8.3.2 U.K.
8.3.2.1 U.K. market estimates and forecast, 2018-2030 (USD Million)
8.3.2.2 Key Country Dynamics
8.3.2.3 Target Disease Prevalence
8.3.2.4 Competitive Scenario
8.3.2.5 Regulatory Framework
8.3.2.6 Reimbursment Scenario
8.3.3 Germany
8.3.3.1 Germany market estimates and forecast, 2018-2030 (USD Million)
8.3.3.2 Key Country Dynamics
8.3.3.3 Target Disease Prevalence
8.3.3.4 Competitive Scenario
8.3.3.5 Regulatory Framework
8.3.3.6 Reimbursment Scenario
8.3.4 France
8.3.4.1 France market estimates and forecast, 2018-2030 (USD Million)
8.3.4.2 Key Country Dynamics
8.3.4.3 Target Disease Prevalence
8.3.4.4 Competitive Scenario
8.3.4.5 Regulatory Framework
8.3.4.6 Reimbursment Scenario
8.3.5 Italy
8.3.5.1 Italy market estimates and forecast, 2018-2030 (USD Million)
8.3.5.2 Key Country Dynamics
8.3.5.3 Target Disease Prevalence
8.3.5.4 Competitive Scenario
8.3.5.5 Regulatory Framework
8.3.5.6 Reimbursment Scenario
8.3.6 Spain
8.3.6.1 Spain market estimates and forecast, 2018-2030 (USD Million)
8.3.6.2 Key Country Dynamics
8.3.6.3 Target Disease Prevalence
8.3.6.4 Competitive Scenario
8.3.6.5 Regulatory Framework
8.3.6.6 Reimbursment Scenario
8.3.7 Sweden
8.3.7.1 Sweden market estimates and forecast, 2018-2030 (USD Million)
8.3.7.2 Key Country Dynamics
8.3.7.3 Target Disease Prevalence
8.3.7.4 Competitive Scenario
8.3.7.5 Regulatory Framework
8.3.7.6 Reimbursment Scenario
8.3.8 Denmark
8.3.8.1 Denmark market estimates and forecast, 2018-2030 (USD Million)
8.3.8.2 Key Country Dynamics
8.3.8.3 Target Disease Prevalence
8.3.8.4 Competitive Scenario
8.3.8.5 Regulatory Framework
8.3.8.6 Reimbursment Scenario
8.3.9 Norway
8.3.9.1 Norway market estimates and forecast, 2018-2030 (USD Million)
8.3.9.2 Key Country Dynamics
8.3.9.3 Target Disease Prevalence
8.3.9.4 Competitive Scenario
8.3.9.5 Regulatory Framework
8.3.9.6 Reimbursment Scenario
8.3.10 Rest of Europe
8.4 Asia-Pacific
8.4.1 Asia-Pacific, SWOT Analysis
8.4.2 India
8.4.2.1 India market estimates and forecast, 2018-2030 (USD Million)
8.4.2.2 Key Country Dynamics
8.4.2.3 Target Disease Prevalence
8.4.2.4 Competitive Scenario
8.4.2.5 Regulatory Framework
8.4.2.6 Reimbursment Scenario
8.4.3 China
8.4.3.1 China market estimates and forecast, 2018-2030 (USD Million)
8.4.3.2 Key Country Dynamics
8.4.3.3 Target Disease Prevalence
8.4.3.4 Competitive Scenario
8.4.3.5 Regulatory Framework
8.4.3.6 Reimbursment Scenario
8.4.4 Japan
8.4.4.1 Japan market estimates and forecast, 2018-2030 (USD Million)
8.4.4.2 Key Country Dynamics
8.4.4.3 Target Disease Prevalence
8.4.4.4 Competitive Scenario
8.4.4.5 Regulatory Framework
8.4.4.6 Reimbursment Scenario
8.4.5 Australia
8.4.5.1 Australia market estimates and forecast, 2018-2030 (USD Million)
8.4.5.2 Key Country Dynamics
8.4.5.3 Target Disease Prevalence
8.4.5.4 Competitive Scenario
8.4.5.5 Regulatory Framework
8.4.5.6 Reimbursment Scenario
8.4.6 South Korea
8.4.6.1 South Korea market estimates and forecast, 2018-2030 (USD Million)
8.4.6.2 Key Country Dynamics
8.4.6.3 Target Disease Prevalence
8.4.6.4 Competitive Scenario
8.4.6.5 Regulatory Framework
8.4.6.6 Reimbursment Scenario
8.4.7 Thailand
8.4.7.1 Thailand market estimates and forecast, 2018-2030 (USD Million)
8.4.7.2 Key Country Dynamics
8.4.7.3 Target Disease Prevalence
8.4.7.4 Competitive Scenario
8.4.7.5 Regulatory Framework
8.4.7.6 Reimbursment Scenario
8.5 Latin America
8.5.1 Latin America, SWOT Analysis
8.5.2 Mexico
8.5.2.1 Mexico market estimates and forecast, 2018-2030 (USD Million)
8.5.2.2 Key Country Dynamics
8.5.2.3 Target Disease Prevalence
8.5.2.4 Competitive Scenario
8.5.2.5 Regulatory Framework
8.5.2.6 Reimbursment Scenario
8.5.3 Brazil
8.5.3.1 Brazil market estimates and forecast, 2018-2030 (USD Million)
8.5.3.2 Key Country Dynamics
8.5.3.3 Target Disease Prevalence
8.5.3.4 Competitive Scenario
8.5.3.5 Regulatory Framework
8.5.3.6 Reimbursment Scenario
8.5.4 Argentina
8.5.4.1 Argentina market estimates and forecast, 2018-2030 (USD Million)
8.5.4.2 Key Country Dynamics
8.5.4.3 Target Disease Prevalence
8.5.4.4 Competitive Scenario
8.5.4.5 Regulatory Framework
8.5.4.6 Reimbursment Scenario
8.6 MEA
8.6.1 Middle East & Africa, SWOT Analysis
8.6.2 South Africa
8.6.2.1 South Africa market estimates and forecast, 2018-2030 (USD Million)
8.6.2.2 Key Country Dynamics
8.6.2.3 Target Disease Prevalence
8.6.2.4 Competitive Scenario
8.6.2.5 Regulatory Framework
8.6.2.6 Reimbursment Scenario
8.6.3 Saudi Arabia
8.6.3.1 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
8.6.3.2 Key Country Dynamics
8.6.3.3 Target Disease Prevalence
8.6.3.4 Competitive Scenario
8.6.3.5 Regulatory Framework
8.6.3.6 Reimbursment Scenario
8.6.4 UAE
8.6.4.1 UAE market estimates and forecast, 2018-2030 (USD Million)
8.6.4.2 Key Country Dynamics
8.6.4.3 Target Disease Prevalence
8.6.4.4 Competitive Scenario
8.6.4.5 Regulatory Framework
8.6.4.6 Reimbursment Scenario
8.6.5 Kuwait
8.6.5.1 Kuwait market estimates and forecast, 2018-2030 (USD Million)
8.6.5.2 Key Country Dynamics
8.6.5.3 Target Disease Prevalence
8.6.5.4 Competitive Scenario
8.6.5.5 Regulatory Framework
8.6.5.6 Reimbursment Scenario
Chapter 9 Competitive Landscape
9.1 Public Companies
9.1.1 Company Market Position Analysis
9.1.2 Competitive Dashboard Analysis
9.1.3 Strategic Framework
9.2 Private Companies
9.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
9.2.2 Regional Network Map
9.3 Company Profiles
9.3.1 Novartis Ag
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 Otonomy, Inc
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 Acousia Therapeutics Gmbh
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 Sensorion
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Pipeline Therapeutics
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 Frequency Therapeutics
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 Astellas Pharma Inc
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Audina Hearing Instruments, Inc.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Ws Audiology A/S
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 Audifon Gmbh & Co. Kg
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 List of Parameters
Table 4 List of Distributors
Table 5 Global Hearing Loss Disease Treatment Market, By Region, 2018-2030 (USD Million)
Table 6 Global Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 7 Global Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 8 Global Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 9 North America Hearing Loss Disease Treatment Market, By Country, 2018-2030 (USD Million)
Table 10 North America Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 11 North America Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 12 North America Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 13 U.S. Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 14 U.S. Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 15 U.S. Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 16 Canada Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 17 Canada Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 18 Canada Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 19 Europe Hearing Loss Disease Treatment Market, By Country, 2018-2030 (USD Million)
Table 20 Europe Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 21 Europe Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 22 Europe Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 23 Germany Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 24 Germany Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 25 Germany Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 26 U.K. Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 27 U.K. Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 28 U.K. Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 29 France Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 30 France Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 31 France Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 32 Italy Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 33 Italy Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 34 Italy Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 35 Spain Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 36 Spain Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 37 Spain Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 38 Denmark Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 39 Denmark Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 40 Denmark Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 41 Sweden Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 42 Sweden Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 43 Sweden Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 44 Norway Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 45 Norway Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 46 Norway Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 47 Asia-Pacific Hearing Loss Disease Treatment Market, By Country, 2018-2030 (USD Million)
Table 48 Asia-Pacific Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 49 Asia-Pacific Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 50 Asia-Pacific Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 51 Japan Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 52 Japan Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 53 Japan Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 54 China Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 55 China Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 56 China Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 57 India Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 58 India Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 59 India Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 60 South Korea Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 61 South Korea Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 62 South Korea Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 63 Australia Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 64 Australia Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 65 Australia Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 66 Thailand Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 67 Thailand Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 68 Thailand Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 69 Latin America Hearing Loss Disease Treatment Market, By Country, 2018-2030 (USD Million)
Table 70 Latin America Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 71 Latin America Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 72 Latin America Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 73 Brazil Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 74 Brazil Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 75 Brazil Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 76 Mexico Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 77 Mexico Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 78 Mexico Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 79 Argentina Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 80 Argentina Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 81 Argentina Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 82 Middle East & Africa Hearing Loss Disease Treatment Market, By Country, 2018-2030 (USD Million)
Table 83 Middle East & Africa Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 84 Middle East & Africa Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 85 Middle East & Africa Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 86 Saudi Arabia Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 87 Saudi Arabia Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 88 Saudi Arabia Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 89 South Africa Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 90 South Africa Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 91 South Africa Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 92 UAE Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 93 UAE Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 94 UAE Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
Table 95 Kuwait Hearing Loss Disease Treatment Market, By Product, 2018-2030 (USD Million)
Table 96 Kuwait Hearing Loss Disease Treatment Market, By Disease Type, 2018-2030 (USD Million)
Table 97 Kuwait Hearing Loss Disease Treatment Market, By End-user, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & Forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Market restraint relevance analysis (Current & future impact)
Figure 12 Penetration & growth prospect mapping
Figure 13 Hearing Loss disease treatment market - PESTLE analysis
Figure 14 Porter’s Five Forces Analysis
Figure 15 Hearing Loss disease treatment market outlook key takeaways
Figure 16 Hearing Loss disease treatment market: Product movement analysis
Figure 17 Global hearing loss disease treatment market, by product, 2018-2030 (USD Million)
Figure 18 Global hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 19 Global devices market, 2018-2030 (USD Million)
Figure 20 Global drugs market, 2018-2030 (USD Million)
Figure 21 Global systemic steroids market, 2018-2030 (USD Million)
Figure 22 Global antiviral medication market, 2018-2030 (USD Million)
Figure 23 Global vasodilators market, 2018-2030 (USD Million)
Figure 24 Global hearing loss disease treatment market: Disease type movement analysis
Figure 25 Global hearing loss disease treatment market, by disease type, 2018-2030 (USD Million)
Figure 26 Global conductive hearing loss market, 2018-2030 (USD Million)
Figure 27 Global sensorineural hearing loss market, 2018-2030 (USD Million)
Figure 28 Global mixed market, 2018-2030 (USD Million)
Figure 29 Global hearing loss disease treatment market: End-user movement analysis
Figure 30 Global hearing loss disease treatment market, by end-user, 2018-2030 (USD Million)
Figure 31 Global otology clinics market, 2018-2030 (USD Million)
Figure 32 Global hospitals market, 2018-2030 (USD Million)
Figure 33 Global ambulatory clinics market, 2018-2030 (USD Million)
Figure 34 Regional market: Key takeaways
Figure 35 Hearing loss disease treatment market regional outlook, 2018 & 2030
Figure 36 North America hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 37 U.S. hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 38 Canada hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 39 Europe hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 40 Germany hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 41 U.K. hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 42 France hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 43 Italy hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 44 Spain hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 45 Denmark hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 46 Sweden hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 47 Norway hearing loss disease treatment market, 2018-2030 (USD Million
Figure 48 Asia-Pacific hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 49 Japan hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 50 China hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 51 India hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 52 South Korea hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 53 Australia hearing loss disease treatment market, 2018-2030 (USD Million
Figure 54 Thailand hearing loss disease treatment market, 2018-2030 (USD Million
Figure 55 Latin America hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 56 Brazil hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 57 Mexico hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 58 Argentina hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 59 Middle East Africa hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 60 South Africa hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 61 Saudi Arabia hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 62 UAE hearing loss disease treatment market, 2018-2030 (USD Million)
Figure 63 Kuwait hearing loss disease treatment market, 2018-2030 (USD Million
Figure 64 Strategy frameworks

Companies Mentioned

  • NOVARTIS AG
  • OTONOMY, INC
  • ACOUSIA THERAPEUTICS GMBH
  • SENSORION
  • PIPELINE THERAPEUTICS
  • FREQUENCY THERAPEUTICS
  • ASTELLAS PHARMA INC
  • AUDINA HEARING INSTRUMENTS, INC.
  • WS AUDIOLOGY A/S
  • AUDIFON GMBH & CO. KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedDecember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 13.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.36 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Hearing Loss Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Hearing Loss Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 171 Pages
  • Global
From
Acute Sensorineural Hearing Loss Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Acute Sensorineural Hearing Loss Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 111 Pages
  • Global
From
Audiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Audiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Canal Hearing Aids Market by Product, Type of Hearing Loss, Patient Type - Global Forecast 2025-2030 - Product Image

Canal Hearing Aids Market by Product, Type of Hearing Loss, Patient Type - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Hearing Aids Market by Component, Product, Technology, Distribution, User Type, Indication - Global Forecast 2025-2030 - Product Image

Hearing Aids Market by Component, Product, Technology, Distribution, User Type, Indication - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From

About the Market

Sensorineural Hearing Loss (SNHL) is a type of hearing loss caused by damage to the inner ear or auditory nerve. It is the most common type of hearing loss and is usually permanent. SNHL is typically treated with hearing aids, cochlear implants, and other assistive devices. In some cases, drugs may be used to treat SNHL. Central Nervous System (CNS) drugs are used to treat a variety of conditions, including SNHL. These drugs are designed to target the auditory nerve and inner ear, and can help improve hearing in some cases. Common CNS drugs used to treat SNHL include corticosteroids, anticonvulsants, and anti-inflammatory drugs. These drugs can help reduce inflammation and improve nerve function, which can help improve hearing. The Sensorineural Hearing Loss Drug market is a rapidly growing sector of the CNS drug market. Companies in this market are focused on developing drugs to treat SNHL, as well as other hearing-related conditions. Some of the major companies in this market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.